Skip to main content
. 2013 Jun 10;13:58. doi: 10.1186/1475-2867-13-58

Table 1.

Patient’s characteristics and their correlations with CD20 Exon2[216] genotype

Clinical parameters No. Genotype
 P* Clinical parameters No. Genotype
 P*
CC CTplusTT CC CTplusTT
Gender
  
  
  
  
 Bulky mass
  
  
  
  
 Male
 83
 63
 20
 0.787
  ≥10cm
 18
 11
 7
 0.249
 Female
 81
 60
 21
  
  <10cm
 146
 112
 34
  
Age
  
  
  
  
 Localized
  
  
  
  
 ≤60
 102
 76
 26
 0.852
  Yes
 25
 19
 6
 0.900
 >60
 62
 47
 15
  
  No
 139
 104
 35
  
B symptoms
  
  
  
  
 No Extra Nodal
  
  
  
  
 Positive
 62
 46
 16
 0.852
  ≤1
 122
 90
 32
 0.535
 Negative
 102
 77
 25
  
  >1
 42
 33
 9
  
LDH
  
  
  
  
 Incidence site
  
  
  
  
 Positive
 77
 55
 22
 0.320
  Lymph node
 93
 68
 25
 0.524
 Negative
 87
 68
 19
  
  Extralymph
 71
 55
 16
  
β2-MG
  
  
  
  
 IPI
  
  
  
  
 Positive
 49
 35
 14
 0.684
  0-2
 114
 84
 30
 0.557
 Negative
 106
 79
 27
  
  3-5
 50
 39
 11
  
Stage
  
  
  
  
 Molecular subtypes
  
  
  
  
 I-II
 75
 55
 20
 0.651
  GCB
 28
 21
 7
 0.868
 III-IV 89 68 21    Non-GCB 113 83 30  

Abbreviations: LDH lactate dehydrogenase level, MG macroglobulin, IPI international prognostic index, GCB germinal centre B cell, *χ2 test.